Amgen invests in TScan’s TargetScan platform for Crohn’s Disease breakthroughs

Amgen invests in TScan’s TargetScan platform for Crohn’s Disease breakthroughs

Submitted by admin on May 9, 2023 - 11:24pm
Source: 
Medical Marketing and Media
News Tags: 
Amgen
TScan
TargetScan
Crohn's Disease
Headline: 
Amgen invests in TScan’s TargetScan platform for Crohn’s Disease breakthroughs
snippet: 

Amgen will pay TScan $30 million up front, with $500 million in potential milestone payments, for its proprietary target discovery platform TargetScan.

Do Not Allow Advertisers to Use My Personal information